The limits and challenges of antiobesity pharmacotherapy

KM Gadde, KD Atkins - Expert opinion on pharmacotherapy, 2020 - Taylor & Francis
Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …
被引用次数：46 相关文章
[HTML] nih.gov

[HTML][HTML] The limits and challenges of antiobesity pharmacotherapy

KM Gadde, KD Atkins - Expert opinion on pharmacotherapy, 2020 - ncbi.nlm.nih.gov
Introduction: Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered: This review covers the …

The limits and challenges of antiobesity pharmacotherapy

KM Gadde, KD Atkins - Expert opinion on …, 2020 - pubmed.ncbi.nlm.nih.gov
Introduction Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered This review covers the …

The limits and challenges of antiobesity pharmacotherapy.

KM Gadde, KD Atkins - Expert Opinion on Pharmacotherapy, 2020 - europepmc.org
Introduction: Pharmacotherapy is a useful adjunct when patients with obesity are unable to
achieve adequate benefit from lifestyle interventions. Areas covered: This review covers the …